EPHB3
Reaktivität: Human
WB, ELISA
Wirt: Maus
Monoclonal
1E12
unconjugated
Applikationshinweise
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Buffer
In 1x PBS, pH 7.4
Handhabung
Aliquot to avoid repeated freezing and thawing.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Schauer, Stoecklein, Theisen, Kröpil, Baldus, Hoelscher, Feith, Bölke, Matuschek, Budach, Knoefel: "The simultaneous expression of both ephrin B3 receptor and E-cadherin in Barrett`s adenocarcinoma is associated with favorable clinical staging." in: European journal of medical research, Vol. 17, pp. 10, (2012) (PubMed).
Rönsch, Jäger, Schöpflin, Danciu, Lassmann, Hecht: "Class I and III HDACs and loss of active chromatin features contribute to epigenetic silencing of CDX1 and EPHB tumor suppressor genes in colorectal cancer." in: Epigenetics : official journal of the DNA Methylation Society, Vol. 6, Issue 5, pp. 610-22, (2011) (PubMed).
Ishii, Nakajima, Ogawa: "Complementary expression of EphB receptors and ephrin-B ligand in the pyloric and duodenal epithelium of adult mice." in: Histochemistry and cell biology, Vol. 136, Issue 3, pp. 345-56, (2011) (PubMed).
Ogawa, Takemoto, Ishii, Pasquale, Nakajima: "Complementary expression and repulsive signaling suggest that EphB receptors and ephrin-B ligands control cell positioning in the gastric epithelium." in: Histochemistry and cell biology, Vol. 136, Issue 6, pp. 617-36, (2011) (PubMed).
Schauer, Janssen, Rimkus, Raggi, Feith, Friess, Theisen: "Microarray-based response prediction in esophageal adenocarcinoma." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 16, Issue 1, pp. 330-7, (2010) (PubMed).